Undetectable hs-cTnT in the Emergency Department and Risk of Myocardial Infarction  by Cullen, Louise et al.
Letters J A C C V O L . 6 4 , N O . 6 , 2 0 1 4
A U G U S T 1 2 , 2 0 1 4 : 6 2 8 – 3 4
632value of hs-cTnT to rule out myocardial infarction in
chest pain patients in the emergency department.
After investigating 14,636 patients who sought med-
ical attention for chest pain, the investigators
concluded that patients with chest pain who have an
initial hs-cTnT level of <5 ng/l and no signs of
ischemia on an electrocardiogram (ECG) can be safely
discharged directly from the emergency department.
This work is very meaningful for relieving medical
burden.
However, the original study did not mention a very
common issue—the duration of the onset of chest
pain. Although the time of the ﬁrst detectable low-
level elevation of hs-cTnT has become shorter
compared with conventional troponin T, it still needs
90 to 180 min after the event (3). This means that
within about 1.5 to 3 h after the onset of chest pain,
the hs-cTnT level may be undetectable even if
the patient is having a myocardial infarction. Corre-
spondingly, in the original study, 15 patients with
undetectable hs-cTnT and no signs of ischemia on
the ECG had a ﬁnal diagnosis of myocardial infarc-
tion, of which 13 patients had hs-cTnT <5 ng/l within
3 h after the onset of chest pain, and 11 of the 13
patients were found to have hs-cTnT elevation after
3 h (2). Therefore, we presumed that the negative
predictive value for myocardial infarction with un-
detectable hs-cTnT within 3 h after the onset of chest
pain was much lower than what the original study
reported. Given a lot of patients with chest pain are
going to the emergency department within 3 h (4),
the low negative predictive value of hs-cTnT might
render a number of missed diagnoses. As a conse-
quence, we considered that the conclusion of the
original study was too arbitrary, which might inad-
vertently mislead clinicians into making mistakes.
Besides, a diurnal hs-cTnT rhythm was detected by
Klinkenberg et al. (5). The diurnal variation of hs-
cTnT was characterized by peak concentrations dur-
ing the morning hours (by 08:30 h), gradually
decreasing values during the daytime (until 20:30 h),
and rising concentrations during the nighttime (until
08:30 h the next day) (5), which might also affect
the accuracy of hs-cTnT on predicting myocardial
infarction.
In conclusion, we think the utilization of hs-cTnT
should be combined with the duration of the events
and the diurnal hs-cTnT rhythm.Wei Liu, MD
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in the Emergency
Department and Risk of
Myocardial InfarctionWe read with great interest the recent publication by
Bandstein et al. (1), and congratulate the authors on
their thought-provoking results. If the ﬁndings are
substantiated, then such an approach could have a
major impact on the resources and time required to
investigate patients with possible cardiac chest pain.
The conclusion is emphatically worded: “All patients
with chest pain who have an initial hs-cTnT level
of <5 ng/l and no signs of ischemia on ECG [electro-
cardiogram] have a minimal risk of MI [myocardial
infarction] or death within 30 days and can be safely
discharged directly from the ED [emergency depart-
ment].” We therefore ask the authors whether they
believe that such an investigative approach is ready for
widespread international uptake without further
external validation using robust recruitment and
follow-up processes? The impressive size of the study
was achievable only by making a number of method-
ological compromises that we shall discuss in the
following text.
First, this was an observational trial, and no
patients were actually discharged by virtue of their
ﬁndings. In fact, at least 21% were hospitalized using
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633unknown criteria, many for as long as 4 to 5 days (mean
length of stay was 1.5 days), where it’s likely that they
underwent further investigation and risk modiﬁcation
despite an initial single negative troponin test. One
must assume hospitalization resulted in at least some
element of risk mitigation.
Furthermore, Bandstein et al. (1) report that 89%
(n ¼ 1,704) of those with an initial troponin<5 ng/l had
a second test. The total “low-risk population” who
had serial troponin tests was 1,917 patients. Thus, of
the 8,907 with an initial troponin <5 ng/l, only 19%
(n ¼ 1,704) had serial troponin testing? If correct, this
practice is inconsistent with either the European
Society of Cardiology or American Heart Association/
American College of Cardiology guidelines. Were
many of the initial troponins ordered inappropriately
for clinical scenarios later not considered to be
consistent with acute coronary syndrome?
Of patients with a second troponin test per-
formed, 3% (44 of 1,704) of levels were elevated. If
not an acute MI (AMI), what were their diagnoses?
And, if the 3% elevated second troponin rate was
applied to the single troponin low-risk cohort, an
additional 210 patients may have had an elevated
second troponin. Without a second troponin level,
how can it be claimed that an elevation wasn’t pre-
sent? By not using a standard AMI evaluation, is it
possible that missed AMI occurred and were not
found upon follow-up simply because the patient
didn’t die? Further, 39 patients were diagnosed with
MI by 30 days, implying a 2% (39 of 1,917) event rate.
If this event rate is also applied to the low-risk
population with a single troponin level, it is
possible that as many as 140 MIs were missed simply
because the patients weren’t tested nor dead in
1 year.
Ultimately, the suggested approach needs the
further support of an interventional trial with accu-
rate follow-up and in which data are collected
to measure the effect of the investigators’ recom-
mendation. Until this consideration is validated, the
“one and done” troponin strategy should only be
considered as hypothesis generating.*Louise Cullen, MB, BS
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Testing Time Is Also a Learning TimeWe would like to express our gratitude to Dr. Liu and
colleagues and Dr. Cullen and colleagues for their
letters regarding our recently published paper (1).
Firstly, we do agree that our ﬁndings need to be
validated in other settings than a university hospital,
with a different diversity of ethnicity, socioeconomic
status, and prevalence of cardiovascular disease.
All patients who were included in our study had
chest pain, an electrocardiogram (ECG) recorded, and
at least 1 troponin level measured (1). To our knowl-
edge, troponins are not used for any other reasons
than to conﬁrm or to exclude myocardial ischemia. In
addition, all patients had a clinical assessment made,
which we believe is common practice. Occasionally,
patients were assessed clinically after the troponin
level was available, and an explanation for the chest
pain other than a myocardial infarction (MI) would
lead to a discharge home. We believe that this is in
line with how patients with chest pain are assessed in
most emergency departments (ED).
Seventy-seven percent of admitted patients went
home the same or the next day. Naturally, diagnoses
such as pneumonia, pulmonary embolism, or atrial
ﬁbrillation may have necessitated longer hospital
stays. Our primary aim was not to investigate risk
mitigation in admitted versus discharged patients.
We believe that exercise tests, stress echocardio-
grams, or coronary angiograms by themselves have
no impact on prognosis. We do acknowledge that
there may have been patients discharged who may
have had a second troponin >14 ng/l if measured.
However, the risk of all-cause mortality was not
higher in patients discharged versus admitted, and
there were only 2 cardiovascular deaths within 12
months in 8,907 patients with troponins <5 ng/l,
which indicates an excellent long-term prognosis.
In a random sample of 100 patients, the mean time
to measurement of troponins was 2.5 h. Thus, most
patients had their ﬁrst troponin level evaluated
